Diltiazem Fails to Improve Vasomotor Dysfunction, Angina in ANOCA Diltiazem Fails to Improve Vasomotor Dysfunction, Angina in ANOCA

In patients with angina and no coronary artery disease, 6 weeks of diltiazem did not improve coronary function test results, apart from epicardial spasm, or angina symptoms in the EDIT-CMD trial.Medscape Medical News

Source: Medscape Cardiology Headlines - April 3, 2022 Category: Cardiology Tags: Cardiology News Source Type: news